FDA approves two Abbott intraocular lenses; NFL, GE and NIST award $2M for new materials;

@FierceMedDev: Stomach-draining obesity startup gets $12M in debt to support PMA in mid-2015. More | Follow @FierceMedDev

@EmilyWFierce: Roche and Qualcomm join forces for next-gen remote patient monitoring system. Story | Follow @EmilyWFierce

> The NFL, GE ($GE) and sports equipment maker Under Armour joined the U.S. Department of Commerce's National Institute of Standards and Technology (NIST) to launch an innovation competition to advance materials that better absorb energy. Dubbed, the Head Health Challenge III, the awards are for $2 million and is part of the larger $60 million multi-year initiative announced last year. Six finalists will receive $250,000, while the winner will receive an additional $500,000. Release

> New eye-tracking technology developed by researchers at NYU Langone Medical Center can help to identify traumatic brain injury patients after watching a four minute video. Story

> The FDA approved and Abbott Laboratories ($ABT) launched two multifocal, implantable intraocular lenses for cataract patients. Release

> Ortho-Clinical Diagnostics has partnered with Quotient to market its MosaiQ transfusion diagnostic platform that is in development and is expected to offer faster and more comprehensive results regarding matching donor and patient blood. Under the deal, OCD will pay up to $59 million and it will also invest $10 million in the startup. Release

Biotech News

@FierceBiotech: Obama wants $215M to kick off 'precision medicine' project. More | Follow @FierceBiotech

@JohnCFierce: $ICPT up 38% this a.m., which is nuts. Article | Follow @JohnCFierce

@DamianFierce: The to-my-knowledge guest list for tomorrow's White House precision medicine thing: $FMI, $VRTX, $MRK, $REGN. | Follow @DamianFierce

> Obama wants $215M to kick off 'precision medicine' project. Story

> Pfizer bails on a $70M rare disease deal with Repligen. More

> Spark nails a $161M IPO to fund its 'breakthrough' gene therapy. News

Pharma News

@FiercePharma: European regulators chart record year for new animal health products. More | Follow @FiercePharma

@EricPFierce: GSK is moving forward with its new API plant in Scotland. Story | Follow @EricPFierce

> Study of all data on Roche's highly debated Tamiflu says it does help. More

> Viehbacher's ouster, severance raise red flags for CEO candidates. News

Suggested Articles

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.